Latest News: Health insights
CanSinoBIO’s mRNA Covid Vaccine Cleared For Trials in China
Monday April 4, 2022
Chinese vaccine developer CanSino Biologics said on Monday its potential Covid-19 vaccine using mRNA technology has been approved by the medical products regulator to enter clinical trials
Inside Wuhan’s Secretive National Biosafety Lab
Wednesday April 8, 2020
Experts raised concerns about the Wuhan lab during an accreditation process - concerns that were amplified after the Covid-19 pandemic spread from the same city
-
« Previous
1
…
11
12
13
ABOUT AF
RESOURCES
LEGAL + PRIVACY
DISCLAIMER
Asia Financial is owned by Capital Link International Holdings Ltd, 902, Wilson House 19-27 Wyndham Street, Central, Hong Kong. www.capitallinkintl.com
